States / Texas / HB 3057

HB 3057 Enacted

Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Compare versions →
Enrolled — · 571 words Open full page ↗

H.B. No. 3057

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.